RT Journal Article
SR Electronic
T1 What delirium detection tools are used in routine clinical practice in the UK? A Freedom of Information investigation of UK hospitals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.12.21249699
DO 10.1101/2021.01.12.21249699
A1 Zoë Tieges
A1 Jacqueline Lowrey
A1 Alasdair M. J. MacLullich
YR 2021
UL http://medrxiv.org/content/early/2021/01/15/2021.01.12.21249699.abstract
AB Purpose Our aim was to collect information on delirium assessment processes and pathways in non-intensive care settings in the UK.Methods We sent a Freedom of Information request to 169 UK NHS hospitals, trusts and health boards (units) in July 2020 to obtain data on usage of delirium assessment tools in clinical practice and delirium pathways or guidelines.Results We received responses from 154 units (91% response rate). 146 (95%) units reported use of formal delirium assessment processes and 131 (85%) units had guidelines or pathways in place. The 4AT was the most widely used tool, with 117 (80%) units reporting use. The Confusion Assessment Method was used in 652 (45%) units, and the SQiD in 52 (36%) units.Conclusions Our findings show that the 4AT is the most commonly-used tool in the UK, with 80% of units reporting implementation. This study adds to our knowledge of real-world implementation of delirium detection methods at scale.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicable.Funding StatementThis work was supported by the Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund. Grant no. IS3-T06/03. The financial sponsor played no role in the design, execution, analysis and interpretation of data or writing of the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As the Freedom of Information Act was used to request data and no person identifiable data were sought, there were no aspects to this study requiring ethics committee approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesInformation gained through FOI Act is publicly available.